Making skincare simple, effective, and tailored for Indian needs.
Our mission is to establish a strong presence across prescription, consumer, aesthetic, and biologics segments with therapies that are science-driven and evidence-based. We are committed to addressing real gaps in skin health and empowering people with lasting confidence.
At Emcutix, our therapies cover the full spectrum of skin health, from everyday conditions to advanced in-clinic care.
At Emcutix, we believe dermatology is not just about treatment. It’s about helping people feel confident and live better. With this belief at our core, we’re building a world-class dermatology organisation backed by science, collaboration and purpose, and one that aims to make a lasting difference.
Whole-Time Director & CEO
Emcutix Biopharmaceuticals
Emcutix, in collaboration with Mantra Pharma Canada, introduced Ureaderm 10% and 20%, advanced urea-based moisturizers formulated with MLFAE™ Technology to deliver long-lasting hydration and barrier repair. This partnership brings Canadian dermatological innovation to India’s clinical skincare segment.
Emcutix holds exclusive rights in India to import, promote, and distribute PRX-Plus, a non-invasive skin tightening and brightening system that rejuvenates, brightens and firms the skin without injections or downtime. It has been used in more than 6 million procedures globally with no reported side effects and is suitable for all skin types.
Emcutix is closing the gaps that still exist in dermatology by tackling skin concerns like acne, hyperpigmentation, and fungal infections while advancing into aesthetics and beyond. With a growing pipeline and global collaborations, we’re here to set a higher bar for dermatology.
We have collaborated with global leaders in dermatology to bring proven and effective solutions to India. From PRX-Plus, a breakthrough non-invasive skin rejuvenation treatment, to Ureaderm moisturisers, our partnerships ensure patients and doctors have access to trusted science-led solutions.
Built by leaders who’ve shaped some of the most successful dermatology brands, Emcutix combines strategic expertise with scientific insights to redefine modern skin care. Our strong partnership between researchers and business leaders drives the creation of trusted, high-quality skin care solutions.
All-skin Compatible
No Frost/Peeling
Needle-free Therapy
What our customers are saying
Emcutix Biopharmaceuticals Limited is a wholly owned subsidiary of Emcure Pharmaceuticals, established in October 2024 with a singular focus on dermatology. We aim to address key therapy gaps across prescription, consumer, aesthetic, and biologic segments.
Our growing dermatology portfolio includes trusted solutions like AquaOat for sensitive skin, Ureaderm for long-lasting hydration, Flawlizo for acne management, Emtofa immunomodulator tablets, Blaxtin anti-allergic tablets, Solglo sun protection, and advanced in-clinic innovations such as PRX-PLUS.
PRX-PLUS is a non-invasive, pain-free skin biostimulator trusted by dermatologists worldwide. The treatment works by penetrating the deeper layers of skin and stimulating natural skin regeneration. It helps improve skin brightness, firmness, and texture, without needles, peeling, or downtime.
We cover multiple therapy areas in dermatology, including acne care, anti-fungal treatments, sunscreen and hyperpigmentation, moisturising and barrier repair, emollient & protective therapy, aesthetics and skin brightening, immunomodulator, and anti-allergic therapies.
Our focus is solely on building a world-class dermatology segment in India, backed by global partnerships and science-led products. We have a team of dermatology experts, researchers, and business leaders who work in synergy to deliver quality products.
Be the first to hear about new launches, skin insights, and insider stories.
